Pacira BioSciences, Inc.
NASDAQ:PCRX
Overview | Financials
Company Name | Pacira BioSciences, Inc. |
Symbol | PCRX |
Currency | USD |
Price | 17.7 |
Market Cap | 816,446,130 |
Dividend Yield | 0% |
52-week-range | 11.16 - 35.95 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. David M. Stack |
Website | https://www.pacira.com |
An error occurred while fetching data.
About Pacira BioSciences, Inc.
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD